382 related articles for article (PubMed ID: 16417699)
21. Triple marker screening in native Japanese women.
Onda T; Kitagawa M; Takeda O; Sago H; Kubonoya K; Iinuma K; Bradley LA; Canick JA; Krasikov NE; Ponting NR; Grier RE
Prenat Diagn; 1996 Aug; 16(8):713-7. PubMed ID: 8878280
[TBL] [Abstract][Full Text] [Related]
22. False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome.
Baxi L; Brown S; Thaker HM
Fetal Diagn Ther; 2007; 22(4):318-20. PubMed ID: 17361088
[TBL] [Abstract][Full Text] [Related]
23. Prenatal biochemical diagnostics of inborn developmental defects.
Malbohan I; Fialová L; Mikulíková L; Hájek Z
Sb Lek; 1994; 95(4):277-83. PubMed ID: 8867698
[TBL] [Abstract][Full Text] [Related]
24. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
[TBL] [Abstract][Full Text] [Related]
25. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
26. [Triple screening for trisomy 21: prospective results of 7039 assessments].
Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
[No Abstract] [Full Text] [Related]
27. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
Huderer-Duric K; Skrablin S; Kuvacic I; Sonicki Z; Rubala D; Suchanek E
Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):49-55. PubMed ID: 10659916
[TBL] [Abstract][Full Text] [Related]
28. Risk estimation in Down's syndrome screening.
Wald NJ; Hackshaw AK
Prenat Diagn; 1996 Nov; 16(11):1055-7. PubMed ID: 8953642
[No Abstract] [Full Text] [Related]
29. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
Reynolds T; Ellis A; Jones R
Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
[TBL] [Abstract][Full Text] [Related]
30. [Prioritization and the "triple"-test in prenatal diagnosis].
Pedersen KM
Ugeskr Laeger; 1999 Dec; 161(50):6901. PubMed ID: 10643374
[No Abstract] [Full Text] [Related]
31. Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.
Rausch DN; Lambert-Messerlian GM; Canick JA
West J Med; 2000 Sep; 173(3):180-3. PubMed ID: 10986181
[TBL] [Abstract][Full Text] [Related]
32. Seeking other disorders within antenatal serum screening programmes for Down's syndrome.
Wald NJ; Canick JA
J Med Screen; 2002; 9(4):145-6. PubMed ID: 12518002
[No Abstract] [Full Text] [Related]
33. Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers.
Hackshaw AK; Wald NJ
Prenat Diagn; 2001 Jan; 21(1):58-61. PubMed ID: 11180243
[TBL] [Abstract][Full Text] [Related]
34. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
Shackley P; McGuire A; Boyd PA; Dennis J; Fitchett M; Kay J; Roche M; Wood P
J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977
[TBL] [Abstract][Full Text] [Related]
35. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
Hogge WA; Fraer L; Melegari T
Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
[TBL] [Abstract][Full Text] [Related]
36. Trisomy 9 screened positive for trisomy 18 by maternal serum screening.
Khoury-Collado F; Anderson VM; Haas BR; Fisher AJ; Bombard AT; Weiner Z
Prenat Diagn; 2004 Oct; 24(10):836-8. PubMed ID: 15503288
[No Abstract] [Full Text] [Related]
37. Prenatal screening for trisomy 18.
Reynolds TM; Wierzbicki A
Prenat Diagn; 1996 May; 16(5):475-6; author reply 477-8. PubMed ID: 8844010
[No Abstract] [Full Text] [Related]
38. [Early pregnancy serum screening in Helsinki: results and mothers' opinions].
Salonen R; Turpeinen U; Kurki L; Lappalainen M; Ammälä P; Hiilesmaa V; Teramo K; von Koskull H; Gahmberg N; Stenman UH
Duodecim; 1997; 113(24):2548-55. PubMed ID: 10892162
[No Abstract] [Full Text] [Related]
39. [Health Council of Netherlands recommendation 'Serum screening for risk assessment of Down syndrome for all women' poorly supported].
Hamerlynck JV; Knuist M
Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2014-7. PubMed ID: 11695097
[TBL] [Abstract][Full Text] [Related]
40. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
van den Boer-van den Berg JM; Dupuis HM
Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
